Rifampicine Labatec 150 mg, gélules
7680502640176
CH-50264
Kapseln
Associated product:
RIFAMPICIN Labatec caps 150 mg 80 pce
1 / 3
google
Article details
- Package size
- 80
- Selling units
- 80
- Measure
- Kapsel(n)
- Galenic form
- Kapseln
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
10.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 77.95
Specialties list
Yes
Generic
No
SL addition date:
15/03/1995
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 50264
- Drug name
- Rifampicine Labatec, gélules
- Galenic form
- KAHA
- ATC Code
- J04AB02
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 11/08/1989
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.02.1.
- Domain
- Human medicine
Package details
- Description (FR)
- RIFAMPICIN Labatec caps 150 mg 80 pce
- Description (DE)
- RIFAMPICIN Labatec Kaps 150 mg 80 Stk
- Market launch
- 11/08/1989
- Narcotic (BTM)
- No